PolicySoupstir the potALPHA

S. 2292 (119th)Congressional Activities
Bill Details

Over-the-Counter Monograph Drug User Fee Amendments

Health|Congressional oversightDrug safety, medical device, and laboratory regulation
Sponsor
Jim BanksR
Cosponsors
Support
Bipartisan
Introduced
Jul 15, 2025
Discussions
0
Committee
Committee on Health, Education, Labor, and Pensions
Current stageCommittee

Placed on Senate Legislative Calendar under General Orders. Calendar No. 152.

Introduced
Committee
Floor
President
Law
Bill detailsDiscussionCongressional Activities
New source material

Congressional Activities

Source-heavy congressional process material lives here so the main bill summary can stay focused. Use this tab for committee scheduling, hearings, CRS analysis, committee publications, and amendment text.

Committee meetings1

CRS Reports

Nonpartisan Congressional Research Service analysis linked directly to this bill.

0 items

No CRS reports linked to this bill yet.

Committee Meetings

Scheduled or recent committee meetings that mention this bill, plus agenda materials and witness documents.

1 item

Committee meetings

Recent
ScheduledMeeting•Jul 30, 2025, 2:00 PM
Business meeting to consider S.2292, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, S.1440, to amend title II of the Public Health Service Act to include as an additional right or privilege of commissioned officers of the Public Health Service (and their beneficiaries) certain leave provided under title 10, United States Code to commissioned officers of the Army (or their beneficiaries), S.2398, to reauthorize the Kay Hagan Tick Act, S.2301, to reauthorize certain programs regarding rural health care, S.1728, to amend the Employee Retirement Income Security Act of 1974 to expand the membership of the Advisory Council on Employee Welfare and Pension Benefit Plans to include representatives of employee ownership organizations, and S.2403, to amend the Employee Retirement Income Security Act of 1974 to provide a clear definition of adequate consideration for certain closely held stock.
430, Dirksen Senate Office Building, 430, Dirksen Senate Office Building
Video
Business meeting to consider S.2292, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, S.1440, to amend title II of the Public Health Service Act to include as an additional right or privilege of commissioned officers of the Public Health Service (and their beneficiaries) certain leave provided under title 10, United States Code to commissioned officers of the Army (or their beneficiaries), S.2398, to reauthorize the Kay Hagan Tick Act, S.2301, to reauthorize certain programs regarding rural health care, S.1728, to amend the Employee Retirement Income Security Act of 1974 to expand the membership of the Advisory Council on Employee Welfare and Pension Benefit Plans to include representatives of employee ownership organizations, and S.2403, to amend the Employee Retirement Income Security Act of 1974 to provide a clear definition of adequate consideration for certain closely held stock.Business meeting to consider S.2292, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, S.1440, to amend title II of the Public Health Service Act to include as an additional right or privilege of commissioned officers of the Public Health Service (and their beneficiaries) certain leave provided under title 10, United States Code to commissioned officers of the Army (or their beneficiaries), S.2398, to reauthorize the Kay Hagan Tick Act, S.2301, to reauthorize certain programs regarding rural health care, S.1728, to amend the Employee Retirement Income Security Act of 1974 to expand the membership of the Advisory Council on Employee Welfare and Pension Benefit Plans to include representatives of employee ownership organizations, and S.2403, to amend the Employee Retirement Income Security Act of 1974 to provide a clear definition of adequate consideration for certain closely held stock.

Hearings

Hearings, transcripts, and related meeting references associated with this bill.

0 items

No hearings linked to this bill yet.

Committee Reports

Formal committee rationale and report language published for this bill.

0 items

No committee reports linked to this bill yet.

Committee Prints

Working packets, committee print materials, and related draft text.

0 items

No committee prints linked to this bill yet.

Amendments

Structured amendment records, latest actions, vote references, and text links.

0 items

No amendments linked to this bill yet.